<DOC>
	<DOCNO>NCT01728194</DOCNO>
	<brief_summary>This study may help identify abnormality brain system control ability ignore irrelevant information may contribute development depression old adult .</brief_summary>
	<brief_title>Emotional Cognitive Control Late-Onset Depression</brief_title>
	<detailed_description>Approximately half develop depression late life never depression . The classic view change take place brain age contribute development late-onset depression . This view support relative absence family history late onset depression . This research study recruit 70 old adult late life depression 70 old adult without depression . All participant receive sub-clinical , non-contrast ( magnetic resonance imaging ( MRI ) scan begin study 12 week later completion study . The depressed older participant also receive Food Drug Administration ( FDA ) -approved antidepressant , escitalopram ( Lexapro ) , treatment depressive symptom 12 week . This MRI study may help researcher identify abnormality brain system control ability ignore distraction , control emotion , anticipate reward may contribute development depression old adult . The investigator hope finding promote development test may improve detection old adult risk poor treatment outcome eventually guide development novel treatment depression .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<mesh_term>Neurotransmitter Uptake Inhibitors</mesh_term>
	<criteria>Age : 6085 year , righthanded ; Diagnosis : Major depression , unipolar ( Structured Clinical Interview Diagnostic Statistical Manual ( DSM ) IV ( SCIDR ) DSMIV criterion ) ; Age onset first episode ≥ 60 year three depressive episode ; Severity depression : A 24Item Hamilton Depression Rating Scale ( HDRS ) ≥ 20 . Psychotic depression DSMIV , i.e. , presence delusion SCIDR score high 2 ; High suicide risk , i.e . intent plan attempt suicide near future ; Presence Axis I psychiatric disorder ( unipolar major depression ) substance abuse ; History psychiatric disorder unipolar major depression generalize anxiety disorder ( bipolar disorder , hypomania , dysthymia exclusion criterion ) ; Dementia : Diagnosis dementia DSMIV ; Mild Cognitive Impairment ( MCI ) ; Acute severe medical illness , i.e. , delirium , metastatic cancer , decompensated cardiac , liver kidney failure , major surgery , stroke myocardial infarction three month prior entry ; use drug know cause depression , e.g. , reserpine , alphamethyldopa , steroid , sympathomimetics withdrawal ; Neurological brain disease and/or history electroconvulsive therapy ; History use citalopram escitalopram current episode need drug may interact agent , i.e . drug metabolize 2D6 P450 isoenzyme system ; Current involvement psychotherapy ; Contraindications MRI scan include cardiac pacemaker , metallic object metallic implant contraindicate MRI , cardiac stent , claustrophobia ; Inability speak English ; Corrected visual acuity &lt; 20/70 ; Color blindness .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Depression</keyword>
	<keyword>Depressive Disorder</keyword>
	<keyword>Behavioral Symptoms</keyword>
	<keyword>Mood Disorders</keyword>
	<keyword>Mental Disorders</keyword>
	<keyword>Escitalopram</keyword>
	<keyword>Central Nervous System Agents</keyword>
	<keyword>Therapeutic Uses</keyword>
	<keyword>Pharmacologic Actions</keyword>
	<keyword>Physiological Effects Drugs</keyword>
	<keyword>Muscarinic Antagonists</keyword>
	<keyword>Antidepressive Agents</keyword>
	<keyword>Psychotropic Drugs</keyword>
	<keyword>Serotonin Uptake Inhibitors</keyword>
	<keyword>Neurotransmitter Uptake Inhibitors</keyword>
	<keyword>Serotonin Agents</keyword>
	<keyword>Magnetic Resonance Imaging , Functional</keyword>
	<keyword>fMRI</keyword>
	<keyword>Magnetic Resonance Imaging</keyword>
</DOC>